CoChat

Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial

Open access
Palmieri, A., Imbimbo, C., Creta, M., Verze, P., Fusco, F., Mirone, V. · 2012 · International Journal of Andrology
Cited by 109

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Summary: Extracorporeal shock wave therapy improves erectile function in patients with Peyronie’s disease. However, erectile dysfunction still persists in many cases. We aimed to investigate the effects of extracorporeal shock wave therapy plus tadalafil 5 mg once daily in the management of patients with Peyronie’s disease and erectile dysfunction not previously treated. One hundred patients were enrolled in a prospective, randomized, controlled study. Patients were randomly allocated to receive either extracorporeal shock wave therapy alone for 4 weeks (n = 50) or extracorporeal shock wave therapy plus tadalafil 5 mg once daily for 4 weeks (n = 50). Main outcome measures were: erectile function (evaluated through the shortened version of the International Index of Erectile Function), pain during erection (evaluated through a Visual Analog Scale), plaque size, penile curvature and quality of life (evaluated through an internal questionnaire). Follow‐up evaluations were performed after 12 and 24 weeks. In both groups, at 12 weeks follow‐up, mean Visual Analog Scale score, mean International Index of Erectile Function score and mean quality of life score ameliorated significantly while mean plaque size and mean curvature degree were unchanged. Intergroup analysis revealed a significantly higher mean International Index of Erectile Function score and quality of life score in patients receiving the combination. After 24 weeks, intergroup analysis revealed a significantly higher mean International Index of Erectile Function score and mean quality of life score in patients that received extracorporeal shock wave therapy plus tadalafil. In conclusion extracorporeal shock wave therapy plus tadalafil 5 mg once daily may represent a valid conservative strategy for the management of patients with Peyronie’s disease and erectile dysfunction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2605.2011.01226.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 23

  1. 10.1007/s11934-000-0010-8 · DOI
  2. 10.1590/S1677-55382004000300004 · DOI
  3. 10.1016/j.eururo.2006.02.048 · doi:10.1016/j.eururo.2006.02.048
  4. 10.1185/03007990802498440 · DOI
  5. 10.1111/j.1464-410X.2006.05955.x · DOI · Paper page
  6. 10.1111/j.1743-6109.2008.01104.x · DOI · Paper page
  7. 10.1038/nrurol.2010.24 · DOI
  8. 10.1097/01.ju.0000099891.68488.4e · DOI
  9. 10.1097/01.ju.0000108060.30363.8d · DOI · Paper page
  10. 10.1046/j.1464-410x.2001.02241.x · DOI · Paper page
  11. 10.1038/sj.ijir.3901247 · DOI
  12. 10.1016/S0090-4295(02)01527-3 · DOI
  13. 10.1038/sj.ijir.3900912 · DOI
  14. 10.1111/j.1743-6109.2005.20360.x · DOI · Paper page
  15. 10.1016/S0302-2838(02)00225-7 · DOI
  16. 10.1111/j.1743-6109.2005.20113.x · DOI · Paper page
  17. 10.1016/S0022-5347(06)00270-9 · DOI · Paper page
  18. 10.1016/j.eururo.2009.05.012 · DOI · Paper page
  19. 10.1007/s00120-009-2089-y · DOI
  20. Pryor JP., 1988, Peyronie’s disease and impotence, Acta Urol Belg, 56, 317
  21. 10.1038/sj.ijir.3900472 · DOI · Paper page
  22. 10.1016/j.niox.2003.12.002 · DOI · Paper page
  23. 10.1017/S0266462300161173 · doi:10.1017/s0266462300161173

Cited by

See all 109

Metadata

Authors
Palmieri, A., Imbimbo, C., Creta, M., Verze, P., Fusco, F., & Mirone, V.
Venue
International Journal of Andrology
Publisher
Wiley
Published
2011-11-15
Volume
35
Issue
2
Pages
190-195
ISSN
  • 0105-6263 (ISSN-L)
  • 1365-2605
OpenAlex
W1541254912
Cited by
109
References
2
FWCI
1.58
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial. https://app.cochat.ai/papers/10.1111/j.1365-2605.2011.01226.x
The paper
Palmieri, A., Imbimbo, C., Creta, M., Verze, P., Fusco, F., & Mirone, V. (2012). Tadalafil once daily and extracorporeal shock wave therapy in the management of patients with Peyronie’s disease and erectile dysfunction: results from a prospective randomized trial. International Journal of Andrology. https://doi.org/10.1111/j.1365-2605.2011.01226.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.